Similar articles

• PSA thresholds for prostate cancer detection.

  Parker ME. Parker ME. JAMA. 1997 Sep 3;278(9):699-700; author reply 700-1. doi: 10.1001/jama.1997.03550090023014. JAMA. 1997. PMID: 9286820 No abstract available.
• Study concludes that moderate PSA levels are unrelated to prostate cancer outcomes.

  Vastag B. Vastag B. JAMA. 2002 Feb 27;287(8):969-70. doi: 10.1001/jama.287.8.969. JAMA. 2002. PMID: 11866626 No abstract available.
• Evaluation of changes in PSA in the management of men with prostate cancer.

  Carter HB, Pearson JD. Carter HB, et al. Semin Oncol. 1994 Oct;21(5):554-9. Semin Oncol. 1994. PMID: 7524154 Review. No abstract available.
• Use of prostate-specific antigen (PSA) and PSA density in the detection of stage T1 carcinoma of the prostate.

  Presti JC Jr, Carroll PR. Presti JC Jr, et al. Semin Urol Oncol. 1996 Aug;14(3):134-8. Semin Urol Oncol. 1996. PMID: 8865474 Review.
• Why PSA testing does have value.

  Kirby M. Kirby M. Practitioner. 1997 Jul;241(1576):363. Practitioner. 1997. PMID: 9425708 No abstract available.